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and increment of total platelet count was recorded. The details of the same are as tabulated in Table 1 After platelet transfusions as stated above, he was put on eltrombopag 50 mg once a day with prednisolone 40 mg OD, which was tapered by 5 mg every week. Meanwhile, his bone marrow karyotyping was also done, and chromosomal analysis revealed two cell lines. 40% of cells analyzed revealed apparently normal male karyotype. However, 60% of cells analyzed revealed a total of 162-172 chromosomes depicting hyperheptaploidy as shown in Figure 1 .
Chromosomal abnormalities in ITP are unusual. More so, polyploidy in platelet disorders has been rarely noticed as of
Hyperheptaploidy in idiopathic thrombocytopenic purpura
Editor, Idiopathic thrombocytopenic purpura (ITP) is a condition of low platelet count of no known cause. It is a diagnosis of exclusion. As most causes appear to be related to antibodies against platelets, it is also known as ITP. Although most cases are asymptomatic, very low platelet counts can lead to a bleeding diathesis and purpuric rash. It affects the overall number of platelets rather than their function.
The study of chromosome using the conventional cytogenetic techniques requires actively dividing cells. Ploidy refers to the number of sets of chromosomes present. Thus, diploid would mean two sets of each chromosome. At times, the number of the chromosomes may vary between the two ploidy levels.
Near-heptaploidy has chromosome number ranging from 150 to 172. If the chromosome is in the range of 150-160 it is named as hypoheptaploidy and if between 162 and 172 it is known as hyperheptaploidy. [1] We have previously reported a case of hyperploidy (octaploidy) in ITP which was incidentally noticed. [2] Now, to add to that, another case of hyperheptaploidy has been noted in a case of ITP.
A 31-year-old male was admitted with a chief complaint of postprandial fullness. On routine hemogram, he was found to have very low platelets count of 10,000/mL and was diagnosed as a case of ITP after ruling out other causes of thrombocytopenia. On testing for Vitamin B12 levels, it was found to be within normal limits. He received IV methyl prednisolone 500 mg stat dose which was continued for the following 3 days, but no response was observed. Furthermore, 3 doses of IVIg were given and the patient was still unresponsive. Platelets transfusion was planned yet. In a study by Hwang Y et al., three cases of chromosomal anomalies were noted out of 100 cases of suspected ITP. Clonal chromosomal abnormalities found were der (1;7) (q10;p10), add (9) (q12), or t (7;11) (p22;q12). [3] However, there were no polyploidy detected in any of these cases.
Vitamin B12 deficiency leads to impaired DNA synthesis resulting in G2/M phase arrest. [4] G2/M phase arrest compels the cells to remain in a tetraploid condition. Vitamin B12 might have led to G2/M phase arrest and subsequent tetraploidy. Anyhow, the octaploidy in our previous report and and hyperheptaploidy in the present case cannot be a result of the G2/M phase arrest as in the present case the Vitamin B12 level was normal.
There exists a reported case of near octaploidy in essential thrombocythemia. [5] Our previous report [2] was a case of octaploidy, now this is a case of hyperheptaploidy and both are diagnosed cases of ITP. Whether it is a chance occurrence, or it is an associated finding with ITP needs to be found out in a larger study. Repeat findings in cytogenetic analysis should provoke us to routinely karyotype cases of platelet disorders and explore this untouched field.
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